search
Back to results

Feasibility and Safety of Bile Duct Clearance by Transcystic Sphincter of Oddi Balloon Dilatation (TCPBD)

Primary Purpose

Cholecystolithiasis, Choledocholithiasis, Surgery

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Papillary ballon dilatation
Sponsored by
Insel Gruppe AG, University Hospital Bern
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cholecystolithiasis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • Patients ≥ 18 years of age
  • Patients with gallbladder stones and known or expected concomitant bile duct stones
  • Bile duct stones ≤ 6mm in size measured by intraoperative cholangiography

Exclusion Criteria:

  • Women who are pregnant
  • Declined consent
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
  • Enrolment of the investigator, his/her family members, employees and other dependent persons
  • Patients with moderate or severe acute cholangitis
  • Patients with moderate or severe pancreatitis

Sites / Locations

  • Inselspital Bern (Department for Visceral Surgery and Medicine)

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Papillary ballon dilatation

Arm Description

Outcomes

Primary Outcome Measures

Rate of successful bile duct stone clearance (feasibility)
Intraoperative cholangiogram showing no persistent stones in the common bile duct after the study procedure
Rate of successful bile duct stone clearance (feasibility)
Patient not showing any signs of choledocholithiasis (fever, pale stool, dark urine, right upper quadrant pain, elevated cholestasis parameters) at 6 week follow up

Secondary Outcome Measures

Number of patients with injury to common bile duct
Injury to common bile duct is defined as contrast agent leakage from common bile duct during cholangiography or an obvious lesion.
Intraoperative blood loss
Measured in ml
Intraoperative blood substitution
Number of erythrocyte concentrates (275ml each)
Number of patients with lesion to surrounding organs
stomach, duodenum, liver, small bowel, colon
Number of patients with postoperative bile leak
Bile leakage is defined as bilirubin concentration in the drain fluid at least 3 times the serum bilirubin concentration on or after postoperative day 3 or as the need for radiologic or operative intervention resulting from biliary collections or biliary peritonitis
Number of patients with postoperative significant bleeding
Significant bleeding is defined as a drop in haemoglobin level > 3 g/dl post-operatively compared with the post-operative baseline level and/or any post-operative transfusion of packed red blood cells for a falling haemoglobin and/or the need for radiological intervention (such as embolization) and/or re-operation to stop bleeding
Number of patients with postoperative cholangitis
Cholangitis is defined according to the Tokyo Guidelines 2018 [17]: The guidelines encompass systemic TCPBD-Pilot-Tr ial Version 4.0 of 14.09.2020 Page 29 of 41 inflammation (fever, chills or increased inflammatory markers), cholestasis (jaundice or abnormal liver function tests) and imaging (biliary dilation or evidence of stricture, stone or stent). Diagnosis can be suspected in cases of systemic inflammation and one of the two other parameters. Diagnosis is confirmed if all three parameters are present.
Number of patients with postoperative lipasaemia
Lipasaemia is defined as elevation in serum lipase to ten times or greater than the upper limit of normal. It is measured 4 hours after the intervention
Number of patients with postoperative acute pancreatitis
The diagnosis of acute pancreatitis is defined by the presence of two of the following three criteria: acute onset of persistent, severe, epigastric pain often radiating to the back, elevation in serum lipase or amylase to three times or greater than the upper limit of normal, and characteristic findings of acute pancreatitis on imaging (contrast-enhanced computed tomography, magnetic resonance imaging, or transabdominal ultrasonography)

Full Information

First Posted
December 24, 2020
Last Updated
January 24, 2023
Sponsor
Insel Gruppe AG, University Hospital Bern
search

1. Study Identification

Unique Protocol Identification Number
NCT04737642
Brief Title
Feasibility and Safety of Bile Duct Clearance by Transcystic Sphincter of Oddi Balloon Dilatation
Acronym
TCPBD
Official Title
Feasibility and Safety of Intraoperative Bile Duct Clearance by Sphincter of Oddi Balloon Dilatation: A Prospective Observational Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Completed
Study Start Date
January 4, 2021 (Actual)
Primary Completion Date
July 1, 2022 (Actual)
Study Completion Date
October 9, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Insel Gruppe AG, University Hospital Bern

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To investigate feasibility and safety of intraoperative bile duct clearance by sphincter of Oddi balloon dilatation via cystic duct at cholecystectomy. Primary endpoint: rate of successful bile duct stone clearance (feasibility). Secondary endpoints (safety): rate of peri-interventional complications (injury to the common bile duct, bleeding, injury to surrounding organs: stomach, duodenum, liver) and short-term postoperative complications (bile leak, cholangitis, lipasaemia, pancreatitis, pneumonia). Duration of procedure. Length of hospital stay.
Detailed Description
Standard approach to address common bile duct stones is endoscopic retrograde cholangiography (ERC) with sphincterotomy. Those interventions are performed either before or after gallbladder removal (cholecystectomy), thus, requiring at least two interventions. Moreover, ERC with sphincterotomy is associated with a considerable rate of short and long-term morbidity. The main complications are pancreatitis (2-7%), post sphincterotomy bleeding (1-2%), impaired function of the sphincter with reflux of duodenal content to the bile ducts and a consecutive risk for cholangitis, stone recurrence and even a potential higher risk for cholangiocarcinoma. The aim of this study is to evaluate an alternative surgical approach of bile duct clearance at the time of cholecystectomy. Literature of this approach is scarce; however, it has shown a trend to lower postoperative complications if compared to ERC. The technique of sphincter of Oddi balloon dilatation and bile duct clearance from stones via cystic duct at cholecystectomy has been described in a few case series. These small case series have shown a good success rate of bile stone clearance and low complication rates when applying the balloon dilation technique for smaller stones. The investigators have used this technique in selected cases with good success as well. However, the technique needs to be assessed regarding feasibility and safety in a consecutive group of patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cholecystolithiasis, Choledocholithiasis, Surgery

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
57 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Papillary ballon dilatation
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
Papillary ballon dilatation
Intervention Description
Trans cystic papillary ballon dilatation during cholecystectomy
Primary Outcome Measure Information:
Title
Rate of successful bile duct stone clearance (feasibility)
Description
Intraoperative cholangiogram showing no persistent stones in the common bile duct after the study procedure
Time Frame
During operation, up to 2 hours
Title
Rate of successful bile duct stone clearance (feasibility)
Description
Patient not showing any signs of choledocholithiasis (fever, pale stool, dark urine, right upper quadrant pain, elevated cholestasis parameters) at 6 week follow up
Time Frame
At the 6 week follow up appointment
Secondary Outcome Measure Information:
Title
Number of patients with injury to common bile duct
Description
Injury to common bile duct is defined as contrast agent leakage from common bile duct during cholangiography or an obvious lesion.
Time Frame
During operation, up to 2 hours
Title
Intraoperative blood loss
Description
Measured in ml
Time Frame
During operation, up to 2 hours
Title
Intraoperative blood substitution
Description
Number of erythrocyte concentrates (275ml each)
Time Frame
During operation, up to 2 hours
Title
Number of patients with lesion to surrounding organs
Description
stomach, duodenum, liver, small bowel, colon
Time Frame
During operation, up to 2 hours
Title
Number of patients with postoperative bile leak
Description
Bile leakage is defined as bilirubin concentration in the drain fluid at least 3 times the serum bilirubin concentration on or after postoperative day 3 or as the need for radiologic or operative intervention resulting from biliary collections or biliary peritonitis
Time Frame
From operation up to 6 weeks postoperative
Title
Number of patients with postoperative significant bleeding
Description
Significant bleeding is defined as a drop in haemoglobin level > 3 g/dl post-operatively compared with the post-operative baseline level and/or any post-operative transfusion of packed red blood cells for a falling haemoglobin and/or the need for radiological intervention (such as embolization) and/or re-operation to stop bleeding
Time Frame
From operation up to 6 weeks postoperative
Title
Number of patients with postoperative cholangitis
Description
Cholangitis is defined according to the Tokyo Guidelines 2018 [17]: The guidelines encompass systemic TCPBD-Pilot-Tr ial Version 4.0 of 14.09.2020 Page 29 of 41 inflammation (fever, chills or increased inflammatory markers), cholestasis (jaundice or abnormal liver function tests) and imaging (biliary dilation or evidence of stricture, stone or stent). Diagnosis can be suspected in cases of systemic inflammation and one of the two other parameters. Diagnosis is confirmed if all three parameters are present.
Time Frame
From operation up to 6 weeks postoperative
Title
Number of patients with postoperative lipasaemia
Description
Lipasaemia is defined as elevation in serum lipase to ten times or greater than the upper limit of normal. It is measured 4 hours after the intervention
Time Frame
4 hours after the operation
Title
Number of patients with postoperative acute pancreatitis
Description
The diagnosis of acute pancreatitis is defined by the presence of two of the following three criteria: acute onset of persistent, severe, epigastric pain often radiating to the back, elevation in serum lipase or amylase to three times or greater than the upper limit of normal, and characteristic findings of acute pancreatitis on imaging (contrast-enhanced computed tomography, magnetic resonance imaging, or transabdominal ultrasonography)
Time Frame
From operation up to 6 weeks postoperative

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Informed Consent as documented by signature (Appendix Informed Consent Form) Patients ≥ 18 years of age Patients with gallbladder stones and known or expected concomitant bile duct stones Bile duct stones ≤ 6mm in size measured by intraoperative cholangiography Exclusion Criteria: Women who are pregnant Declined consent Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant Enrolment of the investigator, his/her family members, employees and other dependent persons Patients with moderate or severe acute cholangitis Patients with moderate or severe pancreatitis
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Beat Schnüriger, Prof
Organizational Affiliation
UVCM, Inselspital Bern
Official's Role
Principal Investigator
Facility Information:
Facility Name
Inselspital Bern (Department for Visceral Surgery and Medicine)
City
Bern
ZIP/Postal Code
3010
Country
Switzerland

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Feasibility and Safety of Bile Duct Clearance by Transcystic Sphincter of Oddi Balloon Dilatation

We'll reach out to this number within 24 hrs